Impact of noninvasive home ventilation on long-term survival in chronic hypercapnic COPD: a prospective observational study
Authors:
- 4 August 2007
- journal article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 61 (9) , 1516-1522
Abstract
The long-term benefit from noninvasive ventilation (NIV) in chronic hypercapnic chronic obstructive pulmonary disease (COPD) remains uncertain. Within a prospective observational design, we compared the long-term survival of 140 patients with severe persistent hypercapnic COPD (FEV(1) 28.7 +/- 8.7% predicted; PaCO(2) 60.1 +/- 9.2 mmHg) with (n = 99) or without (n = 41) NIV. End-point was all-cause mortality, determined up to 4 years by Kaplan-Meier analysis. Additionally, Cox's proportional hazards regression and stratification by risk factors was performed. Patients were characterised by anthropometric and functional parameters, comorbidities and medical therapy. Adherence in patients with NIV was high (88.9%), daily ventilator use being 6.4 +/- 2.6 h/day and inspiratory pressures 21.0 +/- 4.0 cmH(2)O. One- and 2-year survival rates were 87.7% and 71.8%, respectively, in patients with NIV vs. 56.7% and 42.0% in patients without NIV. Survival rates were significantly higher in patients with NIV compared to those without this therapy (p = 0.001; hazard ratio 0.380; 95% confidence interval 0.138-0.606). The difference between groups was still significant after adjustment for differences in baseline characteristics. Moreover, stratification by risk factors revealed beneficial effects, particularly in patients with high base excess (BE; > 8.9 mmol/l), low pH (< 7.41), FEV(1) (< 27.5%) haemoglobin (< 13.8 g/dl) or large hyperinflation (residual volume-to-total lung capacity > 189% predicted) upon inclusion (p < 0.05 each). In patients with severe chronic hypercapnic COPD receiving NIV at high inspiratory pressure levels and showing high adherence to this therapy, long-term survival was significantly higher than in non-ventilated patients. Patients displaying more severe disease according to known risk factors seemed to benefit most from long-term NIV.Keywords
This publication has 32 references indexed in Scilit:
- Patterns of home mechanical ventilation use in Europe: results from the Eurovent surveyEuropean Respiratory Journal, 2005
- Epidemiology and Global Impact of Chronic Obstructive Pulmonary DiseaseSeminars in Respiratory and Critical Care Medicine, 2005
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEuropean Respiratory Journal, 2004
- Noninvasive VentilationAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Comparison Between Nocturnal Nasal Positive Pressure Ventilation Combined With Oxygen Therapy and Oxygen Monotherapy in Patients With Severe COPDAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Standardization of Spirometry, 1994 Update. American Thoracic SocietyAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Nasal Pressure Support Ventilation Plus Oxygen Compared With Oxygen Therapy Alone in Hypercapnic COPDAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Lung volumes and forced ventilatory flowsEuropean Respiratory Journal, 1993
- Nocturnal Positive-Pressure Ventilation via Nasal Mask in Patients with Severe Chronic Obstructive Pulmonary DiseaseAmerican Review of Respiratory Disease, 1991
- Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 1987